2011
1
Akita H., Nagano H., Takeda Y., Eguchi H., Wada H., Kobayashi S., Marubashi S., Tanemura M., Takahashi H., Ohigashi H., Tomita Y., Ishikawa O., Mori M., Doki Y. Ep-CAN is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity. Oncogene 30 3468-3476 2011
2
Akita H., Takeda Y., Hoshino H., Wada H., Kobayashi S., Marubashi S., Eguchi H., Tanemura M., Mori M., Doki Y., Nagano H. Mural Nodule in Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas is a Marker of Malignant Transformation and Indication for Surgery. Am J Surgery 202 214-219 2011
3
Dyah Laksmi Dewi, Ishii H., Kano Y., Nishikawa S., Haraguchi N., Sakai D., Satoh T., Doki Y., Mori M. Cancer stem cell theory in gastrointestinal malignancies:recent progress and challenges. J Gastroenterol 24 1145-1157 2011
4
Eguchi H., Nagano H., Tanemura M., Takeda Y., Marubashi S., Kobayashi S., Wada H., Umeshita K., Mori M., Doki Y. A Thick Pancresa Is a Risk Factor for Pancreatic Fistula after a Distal Pancreatectomy:Selection of the Closure Technique according to the Thickness. Dig Surg 28 50-56 2011
5
Hirose H., Ishii H., Mimori K., Tanaka F., Takemasa I., Mizushima T., Ikeda M., Yamamoto H., Sekimoto M., Doki Y., Mori M. The Significance of PITX2 Overexpression in Colorectal Cancer. Surg Oncol 18 3005-3012 2011
6
Iwahori K., Serada S., Fujimoto M., Nomura S., Osaki T., Lee CM., Mizuguchi H., Takahashi T., Ripley B., Okumura M., Kawase I., Kishimoto T., Naka T. Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma. Int J Cancer 129 1005-1017 2011
7
Kainuma S, Taniguchi K, Daimon T, Sakaguchi T, Funatsu T, Kondoh H, Miyagawa S, Takeda K, Shudo Y, Masai T, Fujita S, Nishino M, Sawa Y Does stringent restrictive annuloplasty for functional mitral regurgitation cause functional mitral stenosis and pulmonary hypertension? Circulation 124 S10-7 2011
8
Kanzaki R, Higashiyama M., Oda K., Fujiwara A., Tokunaga T., Maeda J., Okami J., Tanaka K., Shingai T., Noura S., Ohue M., Kodama K. Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma. Am J Surg 202 419-426 2011
9
Kato M., Nakajima K., Nishida T., Yamasaki M., Nishida T., Tsutsui S., Ogiyama H., Yamamoto S., Yamada T., Mori M., Doki Y., Hayashi N. Local resection by combined laparoendoscopic surgery for duodenal gastrointestinal stromal tumor Diag Ther Endosc 2011 1-6 2011
10
Kawamoto M., Tanaka F., Mimori K., Inoue H., Kamohara Y., Mori M. Identification of HLA-A 0201/-A 2402-restricted CTL epitopepeptides derived from a novel cancer/testis antigen,MCAK,and inductionof a specific antitumor immune response. Oncol Rep 25 469-476 2011
11
Kobayashi S., Kobayashi S, Nagano H, Hoshino H, Wada H, Marubashi S, Eguchi H, Takeda Y, Tanemura M, Kim T, Shimosegawa E, Hatazawa J, Doki Y, Mori M. Diagnostic value of FDG-PET for lymp node metastasis and outcome of surgery for biliary cancer. J Surg Oncol 103 223-229 2011
12
Kobayashi S., Miyamoto A., Shimizu J., Kashiwazaki M., Takeda Y., Ueshima S., Kim YK., Kitagawa T., Dono K., Mori M., Doki Y., Nagano H. Comparison of 4-weekly vs. 3-weekly gemcitabine as adjuvant chemotherapy following curative resection for biliary tract cancer: A prospective randomized controlled trial. Journal of Cancer Therapy 2 703-709 2011
13
Kobayashi S., Nagano H., Marubashi S., Wada H., Eguchi H., Takeda Y., Tanemura M., Umeshita K., Doki Y., Mori M. Treatment of borderline cases for curative resection of biliary tract cancer. J Surg Oncol. J Surg Oncol. 104 499-503 2011
14
Kobayashi S., Nagano H., Marubashi S., Wada H., Eguchi H., Tanemura M., Sekimoto M., Umeshita K., Doki Y., Mori M. Experience with the use of fibrin sealant plus polyglycolic acid felt at the cut surface of the liver in laparoscopic hepatectomy. Surg Endosc 25 3590-3596 2011
15
Kobayashi S., Nagano H., Marubashi S., Wada H., Takeda Y., Eguchi H., Tanemura M., Umeshita K., Doki Y., Mori M. Successful adult ABO incompatible living donor liver transplantation: experience with double infusion through the hepatic artery and portal vein. Hepato gastroenterology 58 503-507 2011
16
Kodama T, Takehara T., Hikita H., Shimizu S., Shigekawa M., Tsunemastu H., Li W., Miyagi T., Hosui A., Tatsumi T., Ishida H., Kanto T., Hiramastu N., Kubata S., Takigawa M., Tomimaru Y., Tomokuni A., Nagano H., Doki Y., Mori M., Hayashi N. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice J Clin Invest 121 3343-3356 2011
17
Kurokawa Y., Sasako M., Sano M., Shibata T., Ito S., Nashimoto A., Kurita A., Kinoshita T. Functional outcomes after extended surgery for gastric cancer. Brit J Surg 98 239-245 2011
18
Makino T., Doki Y. Treatment of T4 esophageal cancer. Definitive chemo-radiotherapy vs chemo-radiotherapy followed by surgery. Ann Thorac Cardiovasc Surg 17 221-228 2011
19
Makino T., Fujiwara Y., Takiguchi S., Tsuboyama T., Kim T., Nushijima Y., Yamasaki M., Miyata H., Nakajima K., Mori M., Doki Y. Preoperative T staging of gastric cancer by multi-derector row computed tomography. Surgery 149 672-679 2011
20
Marubashi S., Dono K., Nagano H., Kobayashi S., Takeda Y., Umeshita k., Monden M., Mori M. Efficacy of Minimal Dosage of Calcineurin Inhibitor for Living Donor Liver Transplant Recipients with Preoperative Renal Dysfunction. Hepato Gastroenterology 58 508-511 2011
21
Marubashi S., Nagano H., Wada H., Kobayashi S., Eguchi H., Takeda Y., Tanemura M., Doki Y., Mori M. Donor Hepatectomy for Living Donor Liver Transplamtation: Learning Steps and Surgical Outcome. Dig Dis Sci 56 2482-2490 2011
22
Marubashi S., Nagano H., Wada H., Kobayashi S., Eguchi H., Takeda Y., Tanemura M., Umeshita K., Doki Y., Mori M. Clinical Significance of Alpha-Fetoprotein mRNA in Peripheral Blood in Liver Resection for Hepatocellular Carcinoma. Ann Surg Oncol 18 2200-2209 2011
23
Miyake M., Takemasa I., Matoba R., Tanino M., Nijima S., Ikeda M., Yamamoto H., Sekimoto M., Kuhara S., Okayama T., Monden M., Matsubara K., Mori M. Heterogeneity of colorectal cancers extraction of discriminator gene signatures for parsonalized of prognosis. Int J Oncol 39 781-789 2011
24
Miyasaka M., Hirakawa M., Nakamura K., Tanaka F., Mimori K., Mori M., Honda H.. The endoscopic diagnosis of nonerosive reflux disease using flexible spectral imaging color enhancement image: a feasibility trial. Dis Esophagus 24 395-400 2011
25
Miyashiro I, Kishi K., Yano M., Tanaka K., Motoori M., Ohue M., Ohigashi H., Takenaka A., Tomita Y., Ishikawa O. Laparoscopic detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging. Surg Endosc 25 1672-1676 2011
26
Miyata H., Yamasaki M., Kurokawa Y., Takiguchi S., Nakajima K., Fujiwara Y., E Mori M., Doki Y. Prognostic value of inflammation-based score in patients undergoing preoperative chemotherapy followed by surgery for esophageal cancer. Experimental Therapeutic Med 2 879-886 2011
27
Miyata H., Yamasaki M., Kurokawa Y., Takiguchi S., Nakajima K., Fujiwara Y., Konishi K., Mori M., Doki Y. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol 18 3353-3361 2011
28
Miyata H., Yamasaki M., Kurokawa Y., Takiguchi S., Nakajima K., Fujiwara Y., Mori M., Doki Y. Multimodal treatment for resectable esophageal cancer. Gen Thorac Cardiovasc Surg 59 461-466 2011
29
Miyata H., Yamasaki M., Takiguchi S., Nakajima K., Fujiwara Y., Konishi K., Morii E., Mori M., Doki Y. Prognostic Value of Endoscopic Biopsy Findings After Induction Chemoradiotherapy With and Without Surgery for Esophageal Cncer. Ann Surg 253 279-284 2011
30
Miyoshi N., Ishii H., Nagano H., Haraguchi N., Dyah LD., Kano Y., Nishikawa S., Tanemura M., Mimori K., Tanaka F., Saito T., Nishimura J., Takemasa I., Mizushima T., Ikeda M., Yamamoto H., Sekimoto M., Doki Y., Mori M. Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs. Cell Stem Cell 8 633-638 2011
31
Moriwaki K, Okudo K., Haraguchi N., Takeishi S., Sawaki H., Narimatsu H., Tanemura M., Ishii H., Mori M., Miyoshi E. Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity. Cancer Sci 102 1164-1170 2011
32
Murakami M., Kobayashi S., Marubashi S., Tomimaru Y., Noda T., Wada H., Eguchi H., Takeda Y., Tanemura M., Umeshita K., Doki Y., Mori M., Nagano H. Tyrosine Kinase Inhibitor PTK/ZK Enhances the Antitumor Effects of Interferon-α/5-Fluorouracil Therapy for Hepatocellular Carcinoma Cells. Ann Surg Oncol 18 589-596 2011
33
Nagano H., Wada H., Kobayashi S., Marubashi S., Eguchi H., Tanemura M., Tomimaru Y., Osuga K., Umeshita K., Doki Y., Mori M. Long-Term Outcome of Combined Interferon-α and 5-Fluorouracil Treatment for Advanced Hepatocellular Carcinome with Major Portal Vein Thrombosis Oncology 80 63-69 2011
34
Nakagawa S., Miyoshi N., Ishii H., Mimori K., Tanaka F., Sekimoto M., Doki Y., Mori M. Expression of CLDNI in colorectal cancer: A novel markar for prognosis. Int J Oncol 39 791-796 2011
35
Nakajima K., Tsutsui S., Nishida T., Yasuda K., Sumiyama K., Yahagi N., Saida Y., Kondo H., Doki Y. Steady pressure automatically controlled endoscopy (SPACE): a new modality in gastrointestinal endoscopic intervention. Gastroenterol Endosc 73 154-155 2011
36
Nakajima S., Iijima H., Shinzaki S., Egawa S., Inoue T., Mukai A., Hayashi Y., Kondo J., Akasaka T., Nishida T., Kanto T., Morii E., Mizushima T., Miyoshi E., Tsujii M., Hayashi N. Functional analysis of agalactosyl IgG in inflammatory bowel disease patients. Inflamm Bowel Dis 17 927-936 2011
37
Noda T., Nagano H., Tomimaru Y., Murakami M., Wada H., Kobayashi S., Marubashi S., Eguchi H., Takeda Y., Tanemura M., Umeshita K., Kim T., Wakasa K., Doki Y., Mori M. Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery. Surgery 19 372-377 2011
38
Ogino T., Komoike Y., Ishitobi M., Motomura K., Koyama H., Inaji H. Breast cancer with ipsilateral supraclavicular metastases. Breast J 17 555-557 2011
39
Ohta M., Kasama K., Kawamura I., Inamine S., Wakabayashi G., Tani T., Kuwano H., Doki Y., Atomi Y., Kitajima M. Results of a national survey on laparoscopic bariatric surgery in Japan, 2000-2009. Asian J Endosc Surg 4 138-142 2011
40
Sanada Y., Mizushima T., Kai Y., Nishimura J., Hagiya H., Kurata H., Mizuno H., Uejima E., Ito T. Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis. PLoS One 6 2011
41
Sekimoto M, Takemasa I., Mizushima T., Ikeda M., Yamamoto H., Doki Y., Mori M. Laparoscopic lymph node dissection around the inferior mesenteric artery with preservation of the left colic artery. Surg Endosc 25 861-866 2011
42
Sekimoto M., Nagano H., Fujiwara Y., Watanebe T., Katsu K., Doki Y., Mori M. Two Cases of Gastric Anisakiasis for which Oral Administration of a Medicine Containing Wood Creosote (Seirogan) was Effective Hepato-Gastroenterology 58 1252-1254 2011
43
Shao C., Bai W., Junn JC., Uemura M., Hennessey PT., Zaboli D., Sidransky D., Califano JA., Ha PK. Evaluation of MYB promoter methylation in salivary adenoid cystic carcinoma. Oral Oncol 47 251-255 2011
44
Shukla PJ., Makino T., Trencheva K., Milsom JW. Challenges of improving outcomes of rectal cancer surgery in obese patients. J Am Coll Surg 212 130-131 2011
45
Sohma I., Fujiwara Y., Sugita Y., Moon JH., Yakiguchi S., Miyata H., Yamasaki M., Mori M., Doki Y. Parthnolide, An NF-kB Inhibitor, Suppresses Tumor Growth and Enhaces Response yo Chemotherapy in Gastric Cancer Cancer Genonics & Proteomics 8 39-48 2011
46
Sudo T., Mimori K., Nishida N., Kogo R., Iwaya T., Tanaka F., Shibata K., Fujita H., Shirouzu K., Mori M. Histone deacetylase 1 experssion in gastric cancer. Oncol Rep 26 777-782 2011
47
Takahashi H. , Ikeda M., Takemasa I., Mizushima T., Yamamoto H., Sekimoto M., Doki Y., MoriM. Anal metastasis of colorectal carcinoma origin:implications for diagnosis and treatment strategy. Dis Colon Rectum 54 472-481 2011
48
Takahashi H. , Ishii H., Nishida N., Takemasa I., Mizushima T., Ikeda M., Yokobori T., Mimori K., Yamamoto H., Sekimoto M., Doki Y., Mori M. Significance of Lgr5(+ve) Cancer Stem Cells in the Colon and Rectum. Ann Surg Oncol 18 1166-1174 2011
49
Takiguchi S., Masuzawa T., Hirao M., Imamura H., Kimura Y., Fujita J., Tamura S., Fujiwara Y., Mori M., Doki Y. Pattern of surgical treatment for early gastric cancers in upper third of the stomach. Hepatogastroenterology 58 1823-1827 2011
50
Takiguchi S., Masuzawa T., Hirao M., Imamura H., Kimura Y., Fujita J., Tamura S., Fujiwara Y., Mori M., Doki Y. Pattern of Surgical Treatment for Early Gastric Cancers in Upper Third of the Stomatch Hepato-Gastroenterology 58 1823-1827 2011
51
Tomimaru Y., Eguchi H., Marubashi S., Wada H., Kobayashi S., Tanemura M., Umeshita K., Doki Y., Mori M., Nagano H. Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol 17 3663-3760 2011
52
Tomimaru Y., Eguchi H., Nagano H., Wada H., Kobayashi S., Marubashi S., Tanemura M., Tomokuni A., Takemasa I., Umeshita K., Kanto T., Doki Y., Mori M. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 56 167-175 2011
53
Tomimaru Y., Eguchi H., Wada H., Tomokuni A., Kobayashi S., Marubashi S., Takeda Y., Tanemura M., Umeshita K., Mori M., Doki Y., Nagano H. Synergistic antitumor effect of interferon-β with gemcitabine in interferon-α-non-responsive pancreatic cancer cells. Int J Oncol 38 1237-1243 2011
54
Tomimaru Y., Ide Y., Murata K. Outcome of laparoscopic surgery for colon cancer in elderly patients. Asian J Endosc Surg 4 1-6 2011
55
Tomimaru Y., Miyashiro I., Kishi K., Motoori M., Yano M., Shingai T., Noura S., Ohue M., Ohigashi H., Ishikawa O. Is routine measurement of amylase concentration in drainage fluid necessary after total gastrectomy for gastric cancer. J Surg Oncol 104 274-277 2011
56
Tomokuni A., Eguchi H., Tomimaru Y., Wada H., Kawamoto K., Kobayashi S., Marubashi S., Tanemura M., Nagano H., Mori M., Doki Y. miR-146a suppresses the sensitivity to interferon-alpha in hepatocellular carcinoma cells. Biochem Biophys Res Commun 414 675-680 2011
57
Uemura M. , Ikeda M.,Yamamoto H., Kitani K., Tokuoka M., Matsuda K., Hata Y., Mizushima T., Takemasa I., Sekimoto M., Hosokawa K., Matsuura N., Doki Y., MoriM. Clinicopathological Assessment of Locally Recurrent Rectal Cancer and Relation to Local Re-Recurrence. Ann Surg Oncol 18 1015-1022 2011
58
Uemura M., Yamamoto H., Takemasa I., Mimori K., Mizushima T., Ikeda M., Sekimoto M., Doki Y., Mori M. Hypoxia-inducible adrenomedullin in colorectal cancer. Anticancer Res 31 507-514 2011
59
Wada H., Kakimi K., Isobe M., Uenaka A., Wada H., Sato E., Doki Y., Nakajima J., Seto Y., Yamatsuji T., Naomoto Y., Shiraishi K., Takigawa N., Kiura K., Tsuji K., Iwatsuki K., Oka M., Pan L., Hoffman EW., Old LJ., Nakayama E. A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. Int J Cancer 129 2836-2846 2011
60
Watanabe M., Takemasa M., Kaneko N., Yokoyama Y., Matsuo E., Iwase S., Mori M., Matsuura N., Monden M., Nishimura O. Clinical significance of circulating gelectins as colorectal cancer markers. Oncol Rep 25 1217-1226 2011
61
Yamamoto H., Sekimoto M., Oya M., Yamamoto N., Konishi F., Sasaki J., Yamada S., Taniyama K., Tominaga H., Tsujimoto M., Akamatsu H., Yanagisawa A., Sakakura C., Kato Y., Matsuura N. OSNA-based novel molecular testing for lymph node metastases in colorectal cancer patients: results from a multicenter clinical performance study in Japan. Ann Surg Oncol 18 1891-1898 2011
62
Yamasaki M., Makino T., Masuzawa T., Kurokawa Y., Miyata H., Takiguchi S., Nakajima K., Fujiwara Y., Matsuura N., Mori M., Doki Y. Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in esophageal squamous cell carcinoma. Br J Cancer 104 707-713 2011
63
Yamasaki M., Miyata H., Fujiwara Y., Takiguchi S., Nakajima K., Kurokawa Y., Mori M., Doki Y. Minimally invasive esophagectomy for esophageal cancer: comparative analysis of open and hand-assisted laparoscopic abdominal lymphadenectomy with gastric conduit reconstruction. J Surg Oncol 104 623-628 2011
64
Yamasaki M., Miyata H., Tanaka K., Shiraishi O., Motoori M., Peng YF., Yasuda T., Yano M., Shiozaki H., Mori M., Doki Y. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus. Oncology 80 307-313 2011